Intrauterine Devices Market to Reach More Than USD 14.2 Billion by 2035 from USD 4.7 Billion in 2024, Expanding at 10.6% CAGR

The global intrauterine devices market was valued at US$ 4.7 Bn in 2024 and is estimated to grow at a CAGR of 10.6% from 2025 to 2035, reaching more than US$ 14.2 Bn by the end of 2035. Rising awareness of long-acting reversible contraception, government initiatives supporting family planning, and the introduction of advanced intrauterine devices are contributing to market expansion.

An intrauterine device (IUD) is a long-acting form of contraception inserted into the uterus by a healthcare provider to prevent pregnancy. Depending on the product, IUDs can provide contraception for several years, making them one of the most widely used forms of long-acting reversible contraception (LARC).

The market primarily comprises copper IUDs and hormonal (levonorgestrel) IUDs. Both types generally feature a plastic frame that assumes a T-shaped configuration after insertion and includes strings that extend into the vagina to facilitate removal by a healthcare provider.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86611

Analyst Viewpoint on the Intrauterine Devices Market

Increasing awareness of contraception and the benefits of long-acting reversible contraceptive methods is supporting demand for IUDs. Public health campaigns, educational initiatives, improved access to reproductive healthcare information, and increased awareness among women are contributing to greater acceptance of these devices.

Government-backed family planning initiatives are also supporting market development by improving access to contraceptive services and seeking to reduce unintended pregnancies. IUDs are increasingly incorporated into reproductive healthcare programs because of their long-term contraceptive capabilities.

Product innovation is further contributing to market expansion. Manufacturers are developing devices designed to improve placement, comfort, flexibility, and safety. Emerging technologies include IUDs incorporating shape-memory alloy components intended to help reduce the risk of mal-position and uterine wall perforation.

In May 2023, Sebela Pharmaceuticals announced positive Phase 3 study results for its investigational Copper 175 mm² IUD. The next-generation, low-dose, hormone-free copper IUD demonstrated a 99.0% efficacy rate over three years, with a Pearl Index of 0.96. The trial was conducted across 42 sites in the U.S. and reported a 98.8% placement success rate, with positive feedback from clinicians and participants.

Increasing Awareness of IUD Applications Drives Market Growth

Growing awareness of the different applications and benefits of intrauterine devices is an important factor supporting market growth. Over the past decade, women's healthcare priorities have increasingly emphasized safe, long-acting, and reversible contraceptive options.

Public health campaigns, healthcare providers, educational initiatives, and online information sources are helping women understand the benefits of IUDs compared with short-acting contraceptive methods that require regular user adherence.

One of the key advantages of IUDs is their long duration of protection. Depending on the product type, an IUD can provide contraception for several years following a single insertion. This differentiates IUDs from oral contraceptives and other short-acting methods that require more frequent adherence.

Increasing recognition of the effectiveness and convenience of IUDs is consequently contributing to greater acceptance among women across different age groups and healthcare settings.

The expansion of information regarding available IUD options is also helping women make more informed choices regarding contraception in consultation with healthcare professionals. As awareness continues to increase, the market is expected to benefit from greater utilization of long-acting contraceptive technologies.

Government Initiatives Supporting Family Planning Bolster Market Expansion

Government initiatives designed to prevent unintended pregnancies and improve access to reproductive healthcare are another important driver of the intrauterine devices market.

Governments in several countries are promoting long-acting reversible contraceptives such as IUDs as part of broader family planning strategies. These initiatives aim to improve access to contraceptive services while increasing awareness of available reproductive health options.

Publicly funded family planning programs can provide contraceptive services at reduced or no cost, helping expand access among populations that may otherwise face financial or geographic barriers.

National healthcare agencies and international organizations, including the World Health Organization (WHO) and United Nations Population Fund (UNFPA), are also involved in initiatives supporting reproductive health and access to modern contraceptive methods.

Outreach programs and public healthcare facilities can help improve availability in rural and underserved communities. As governments continue to emphasize family planning and women's healthcare access, these programs are expected to create additional opportunities for IUD adoption.

The availability of newer products with improved insertion mechanisms, flexible designs, and other technological features further complements these efforts by expanding the range of devices available to healthcare providers and patients.

Hormonal IUDs Dominate the Product Type Segment

Based on product type, the global intrauterine devices market is segmented into copper IUDs and hormonal (levonorgestrel) IUDs. Hormonal IUDs dominate the market due to the combination of contraceptive effectiveness and additional benefits associated with their use.

Hormonal IUDs release levonorgestrel and can provide long-term contraception while also helping reduce menstrual bleeding and cramps. This combination of pregnancy prevention and management of menstrual symptoms contributes to their appeal among women.

Depending on the product, hormonal IUDs can provide protection for approximately three to seven years, making them a convenient option for women seeking long-term contraception without the need for frequent intervention.

Increasing awareness of these additional benefits is contributing to demand for hormonal IUDs. Healthcare providers may recommend hormonal IUDs to women seeking both long-term contraception and relief from certain menstrual symptoms.

The growing availability of hormonal products and increasing awareness of their benefits are therefore expected to support the segment's leading position through the forecast period.

→Explore Strategies & Trends - Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86611

North America Leads the Intrauterine Devices Market

North America accounted for the leading share of the global intrauterine devices market and is expected to maintain its dominant position during the forecast period.

The region benefits from broad awareness of IUDs as a reliable contraceptive method, supportive reproductive healthcare policies, family planning initiatives, and growing awareness surrounding women's health.

The U.S. represents the leading market within North America. Increasing utilization of IUDs and greater awareness of their safety, convenience, and long-term contraceptive benefits are supporting demand.

Government programs and policies have also contributed to improving access to contraceptive methods. Programs such as Title X and provisions associated with the Affordable Care Act have supported access to contraceptive services and insurance coverage, contributing to the availability and affordability of IUDs.

Europe represents another significant market, supported by established healthcare systems and growing awareness of long-acting contraceptive options. Asia Pacific is expected to provide substantial growth opportunities as access to reproductive healthcare improves and awareness of modern contraceptive methods increases.

Latin America and the Middle East & Africa are also expected to contribute to market development as governments and healthcare organizations expand family planning initiatives and access to contraceptive services.

Product Innovation Creates New Opportunities

Innovation in IUD design is contributing to the expansion of the market by addressing requirements related to placement, comfort, flexibility, and safety.

Manufacturers and technology developers are exploring new device configurations and materials designed to improve the user experience and reduce potential complications associated with IUD placement.

Shape-memory alloy components represent one area of technological development. Such components can be designed to help maintain appropriate device positioning and potentially reduce risks associated with mal-position or perforation of the uterine wall.

New-generation copper IUDs are also being developed with lower doses of copper and improved insertion mechanisms. These innovations are aimed at providing effective contraception while addressing healthcare provider and patient requirements.

In January 2025, 49Care announced the launch of Yanae, a French-invented copper IUD featuring a flexible inserter designed to facilitate easier and more comfortable IUD insertion. The device became available across Canada through pharmacies beginning January 15, with a suggested retail price of US$ 140.

Such product developments demonstrate the industry's focus on improving insertion procedures and expanding the range of contraceptive devices available to healthcare providers.

Intrauterine Devices Market Segmentation

The global intrauterine devices market is segmented based on product type, age group, and end-user.

By product type, the market is divided into copper IUDs and hormonal (levonorgestrel) IUDs. Hormonal IUDs currently represent the dominant category, supported by their long-term contraceptive benefits and ability to reduce menstrual bleeding and cramps.

Based on age group, the market is categorized into 15–20, 21–34, 35–44, and 45+. Different age groups have varying contraceptive requirements and preferences, creating demand for a range of IUD options.

By end-user, the market comprises hospitals, gynecology clinics, and community healthcare centers. Hospitals and gynecology clinics represent important points of access because IUD insertion and removal require healthcare-provider involvement.

Geographically, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Competitive Landscape

The global intrauterine devices market includes established pharmaceutical, medical device, and women's healthcare companies. Market participants are focusing on product development, strategic partnerships, and expansion of distribution networks to increase access to IUD technologies.

Leading companies include AbbVie, Bayer AG, CooperSurgical Inc., DKT INTERNATIONAL, EUROGINE, S.L., Mona Lisa N.V., OCON Medical Ltd., Pregna International Limited, Prosan International BV, and SMB Corporation of India.

Companies are also partnering with hospitals, gynecology clinics, and community healthcare centers to expand their market presence and improve product availability.

These market participants are profiled based on company overview, financial performance, business strategies, product portfolio, business segments, sales footprint, and recent developments.

Key Development in the Intrauterine Devices Industry

In January 2025, 49Care announced the launch of Yanae, a copper IUD developed in France with a flexible inserter intended to facilitate easier and more comfortable insertion. The product was scheduled to become available across Canada through pharmacies beginning January 15.

The development reflects continued innovation in copper IUD design and highlights efforts to improve the insertion experience while expanding access to modern contraceptive products.

Future Outlook for the Intrauterine Devices Market

The global intrauterine devices market is estimated to increase from US$ 4.7 Bn in 2024 to more than US$ 14.2 Bn by 2035, expanding at a CAGR of 10.6% from 2025 to 2035.

Growing awareness of long-acting reversible contraception is expected to remain a major market driver. Increasing access to healthcare information and educational initiatives is helping women understand the long-term benefits and convenience of IUDs.

Government-backed family planning programs are also expected to contribute to market development by improving access to contraceptive services, particularly among underserved populations. Continued collaboration between national health agencies and international organizations is supporting broader reproductive healthcare initiatives.

Hormonal IUDs are expected to retain their leading position within the product type segment because of their long-term contraceptive capabilities and additional benefits related to menstrual bleeding and cramps. At the same time, innovation in copper IUDs and insertion technologies is expanding product options.

North America is expected to remain the leading regional market, supported by established healthcare infrastructure, awareness of IUDs, reproductive healthcare initiatives, and access to contraceptive services. Asia Pacific and other emerging markets are expected to provide additional opportunities as healthcare access and awareness of long-acting contraceptive options improve.

Overall, increasing contraceptive awareness, supportive family planning initiatives, and continuing product innovation are expected to drive sustained expansion of the global intrauterine devices industry through 2035.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=86611<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Robotic Surgical Microscopy Market

Influenza Diagnostics Market

Interbody Fusion Cages Market

Connected Medical Devices Market

ELISA Analyzers Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com